Investor News
Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems
November 3, 2022
No Comments
PALM BEACH GARDENS, Fla., November 3, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive
Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
October 18, 2022
No Comments
Surgeons in 19 Countries Can Now Take Advantage of FlareHawk’s Minimal Insertion Profile, Multiplanar and Endplate-Conforming Expansion, and Maximum Graft Delivery PALM BEACH GARDENS, Fla.,
Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted
October 10, 2022
No Comments
PALM BEACH GARDENS, Fla., October 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS)
Accelus Investor Contact
Brian Johnston (Gilmartin Group)
ir@accelusinc.com
View the investor disclaimer below:
ir@accelusinc.com
View the investor disclaimer below:
